VFS
ONCY

VSR Financial Services’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

VSR Financial Services’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-119,630
Closed -$54K – 632
2015
Q3 		$54K Sell
119,630
-12,000
-9% -$6.87K 0.01% 558
2015
Q2 		$66K Hold
131,630
– – 0.01% 574
2015
Q1 		$97K Hold
131,630
– – 0.01% 537
2014
Q4 		$70K Hold
131,630
– – 0.01% 559
2014
Q3 		$76K Sell
131,630
-54,300
-29% -$68.8K 0.01% 573
2014
Q2 		$238K Buy
185,930
+7,100
+4% +$10.2K 0.03% 488
2014
Q1 		$324K Sell
178,830
-55
-0% -$93 0.05% 423
2013
Q4 		$277K Buy
178,885
+72,385
+68% +$163K 0.04% 440
2013
Q3 		$260K Buy
106,500
+94,600
+795% +$262K 0.05% 421
2013
Q2 		$34K Buy
+11,900
New +$32.9K 0.01% 511

Other funds holding ONCY

NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
KWMG
King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return
CS
Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

VSR Financial Services's ONCY Position: Q4 2015 in Review

VSR Financial Services sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 119,630 shares — an estimated $54K sold.

VSR Financial Services first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $324K in Q1 2014. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • VSR Financial Services reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • VSR Financial Services sold 119,630 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $54K.
  • VSR Financial Services first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
  • VSR Financial Services's ONCOLYTICS BIOTECH INC position peaked at $324K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on VSR Financial Services's 13F filing for Q4 2015, filed 28 Jan 2016.